Sadatsugu Sakane
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 03, 2026
Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026.
Journal: Journal of gastroenterology
Published: February 21, 2026
Cholesterol-containing lipid crystals can directly stiffen the rat steatotic liver before fibrosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 07, 2026
Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover.
Journal: Nature
Published: September 09, 2025
Mesothelin/Mucin 16 Signaling in Activated Portal Fibroblasts Drives the Development of Cholestatic Fibrosis and Hepatocellular Carcinoma in Aged Female Multidrug Resistance Protein 2 Knockout Mice.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 01, 2025
Aging and Aging-Related Senescence in Liver.
Journal: Seminars in liver disease
Published: July 04, 2025
Single cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitis.
Journal: medRxiv : the preprint server for health sciences
Published: May 19, 2025
ETS1 suppresses hepatic stellate cell activation and liver fibrosis.
Journal: JCI insight
Published: May 05, 2025
Liver Sinusoidal Endothelial Cells Promote Metabolic Dysfunction-associated Steatohepatitis Progression via Interleukin-1R1-mediated Chemokine Production Induced by Macrophage-derived Interleukin-1β.
Journal: Cellular and molecular gastroenterology and hepatology
Published: March 12, 2025
Single-Nuclei RNA Sequencing Shows the Engagement of PPAR-Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR-Delta Agonist Seladelpar.
Journal: PPAR research
Published: February 18, 2025
Author Correction: FBP1 controls liver cancer evolution from senescent MASH hepatocytes.
Journal: Nature
Published: January 31, 2025
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom.
Journal: Journal of gastroenterology
Published: January 07, 2025
Last Updated: 09/26/2026